AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 152 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $84,000 | +71.4% | 28,412 | -14.5% | 0.00% | – |
| Q2 2016 | $49,000 | -90.2% | 33,216 | -75.4% | 0.00% | – |
| Q1 2016 | $499,000 | -63.1% | 135,016 | +0.9% | 0.00% | – |
| Q4 2015 | $1,351,000 | -40.2% | 133,762 | -19.4% | 0.00% | -100.0% |
| Q3 2015 | $2,258,000 | -32.3% | 165,921 | -5.6% | 0.00% | 0.0% |
| Q2 2015 | $3,335,000 | -33.5% | 175,831 | -8.2% | 0.00% | 0.0% |
| Q1 2015 | $5,014,000 | +30.8% | 191,582 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $3,834,000 | -34.7% | 183,121 | +4.2% | 0.00% | -50.0% |
| Q3 2014 | $5,868,000 | -44.7% | 175,782 | -46.8% | 0.00% | +100.0% |
| Q2 2014 | $10,610,000 | +44.4% | 330,638 | +107.8% | 0.00% | -50.0% |
| Q1 2014 | $7,347,000 | -40.4% | 159,092 | -8.4% | 0.00% | -33.3% |
| Q4 2013 | $12,319,000 | -56.4% | 173,605 | -47.3% | 0.00% | -25.0% |
| Q3 2013 | $28,260,000 | +209.4% | 329,560 | +128.6% | 0.00% | +33.3% |
| Q2 2013 | $9,134,000 | – | 144,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |